The early development of the mammalian forebrain involves the massive proliferation of the ventricular zone cells lining the lateral ventricles.
A remnant of this highly proliferative region persists into adult life, where it is known as the subependymal layer. We examined the proliferation kinetics and fates of the mitotically active cells in the subependyma of the adult mouse. The medial edge, the lateral edge, and the dorsolateral corner of the subependymal layer of the rostra1 portion of the lateral ventricle each contained mitotically active cells, but the dorsolateral region had the highest percentage of bromodeoxyuridine (BrdU)-labeled cells per unit area. Repeated injections of BrdU over 14 hr revealed a proliferation curve for the dorsolateral population with a growth fraction of 33%, indicating that 33% of the cells in this subependymal region make up the proliferating population. The total cell cycle time in this population was approximately 12.7 hr, with an S-phase of 4.2 hr. To examine the fate of these proliferating cells, we injected low concentrations of a replication-deficient, recombinant retrovirus directly into the lateral ventricles of adult mice for uptake by mitotically active subependymal cells. Regardless of the survival time postinjection (10 hr, 1 d, 2 d, or 8 d), the number of retrovirally labeled cells per clone remained the same (1 or 2 cells/clone).
This suggests that one of the progeny from each cell division dies. Moreover, the clones remained confined to the subependyma and labeled cells were not seen in the surrounding brain tissue. Thus, while 33% of the dorsolateral subependymal cells continue to proliferate in adult life, the fate of the postmitotic progeny is death.
Proliferation in the embryonic forebrain occurs in the ventricular zone, a region lining the ventricles that gives rise to postmitotic cells that migrate away from the ventricular zone and form the substance of the forebrain. Later in embryonic development, a second proliferative zone appears farther from the ventricular surface, called the subventricular zone. This region also gives rise to neurons and glia of the forebrain. Postnatally, the ventricular zone shrinks to a single layer called the ependyma. The subventricular zone persists into the adult as a mitotically active layer (several cells thick) known as the subependyma (Smart, 196 1; Lewis, 1968; Privat and Leblond, 1972) . This region of mitotic activity in the adult brain is particularly curious, because neither the identity of the dividing cells nor the subsequent fate of the newly formed progeny are definitively known. In normal control animals it has been suggested that these cells migrate out into the adult forebrain to form neuroglia or even neurons (Altman, 1966 (Altman, ,1969 Privat and Leblond, 1972; Paterson et al., 1973) . These suggestions were based on experiments labeling proliferating cells in the adult brain with tritiated thymidine ('H-thy) and the subsequent localization of labeled cells outside of the subependymal layer. Perhaps the subependymal population provides a reserve of cells that at times of stress participates in the large proliferative response seen at sites of injury in the brain (Morshead and van der Kooy, 1990) . To examine the fate of adult subependymal cells, we utilized a replication-deficient, recombinant retrovirus to label the mitotically active cells and then looked for the migration of the labeled progeny out of the subependyma and into the surrounding brain tissue. Retroviral labeling permits unequivocal tracing of the progeny of an infected proliferating cell without dilution of the label. 3H-thy and bromodeoxyuridine (BrdU; a thymidine analog) can be used to investigate the cell cycle kinetics of anatomically defined populations in pre-and postnatal animals (Waechter and Jaensch, 1972; Korr et al., 1973; Lewis et al., 1977; Nowakowski et al., 1989) . We utilized BrdU in a cumulative labeling protocol to determine the proliferation kinetics of the subependymal cells: (1) the length of the cell cycle (r') and the DNA-synthetic phase (Ts) and (2) the growth fraction (GF), which is the proportion of subependymal cells that comprises the proliferating population. The combination of retroviral lineage tracing and BrdU labeling allowed us to conclude that the proliferating cells of the subependyma divide in a stem-cell mode with one postmitotic cell from each division dying.
Materials
and Methods Quantification of the proliferative response. Adult male CD1 mice (25-30 gm) were obtained from Charles River. To study the variation in the baseline proliferative response in the subependyma, in an initial experiment animals were divided into a control group (n = 4) and an experimental "stressed" group (n = 5). Both groups were injected intraperitoneally with physiological saline (0.15 ml) for 7 d. On the test day (day 8), the control group again received the saline solution while the experimental group received an intraperitoneal injection of sodium pentobarbital(65 mg/kg). On day 9, both groups of animals were given intraperitoneal injections of 5 rCi/gm 3H-thy in order to label proliferating cells. The animals were killed 4 hr post-3H-thy with an overdose of sodium pentobarbital and transcardially perfused with 75-100 ml of 4% paraformaldehyde in 0.1 M phosphate buffer. The brains were removed, placed in 15% sucrose, and stored at 4°C. Coronal sections, 32 pm thick, through the rostra1 forebrain were cut on a cryostat (-14°C). Sections were mounted on gelled microscope slides, defatted, and then rehydrated in decreasing concentrations of ethyl alcohol and processed and van der Kooy l Proliferation and Cel l Death i n the Subependyma Figure   1 . Schematic representation of a coronal section through the forebrain of an adult mouse showing the lateral ventricles and the subependymal layer lining them. The subependyma is divided into three regions, the dorsolateral area (dl), the lateral edge (/at), and the medial edge (med). The boxed areas show the portion of each region from which counts of proliferating cells were made. These areas have varying mitotic activity, with the dorsolateral area being the most active, followed by the lateral area and then by the medial area. CC, corpus callosum.
for autoradiography by dipping the slides in liquid emulsion (Kodak NTB-2 nuclear track emulsion). The slides were exposed for approximately 2 months, after which time they were developed with Kodak D-19 developer and Nissl counterstained. A cell was considered labeled if there were five times more silver grains over the cell than over a comparable size area of non-perikaryal surrounding neuropil. The number of labeled subependymal cells surrounding the ventricle, in sections between the caudal portion of the genu of the corpus callosum and the crossing of the anterior commissure, were averaged from two sections (three to seven 350 Frn* fields were counted per section) per animal and expressed per 350 pm*. Nissl-stained cells were counted by focusing through the tissue in the same regions as defined above. The total numbers of cells were averaged from two sections per animal and expressed per 350 pm2.
Cumulative labeling with BrdU to determine proliferation kinetics. In order to label the entire population of proliferating subependymal cells, adult animals were injected with BrdU (65 mg/kg, dissolved in 0.007 N NaOH in 0.9% NaCl) every hour for 14 hr. BrdU is a thymidine analog that is incorporated into the DNA of dividing cells during S-phase and can be visualized by immunocytochemistry.
Animals were killed each hour, 0.5 hr after each of the BrdU injections. A total of at least four animals were killed at each time point by anesthetic overdose and transcardially perfused with 4% paraformaldehyde as described above. The brains were removed and kept overnight in 15% sucrose at 4°C. Sections (32 pm) were cut on a cryostat at -14°C and collected in 0.1 M PBS (4°C). The sections were incubated in 1 M HCl for 30 min at 60°C to denature the DNA. This was followed by 3 x 10 min washes with the washing solution (0.1 M PBS containing 1% normal horse serum and 0.3% Triton X-100). The sections were subseauentlv incubated for 48 hr (4°C) in a primary monoclonal antibody (l-25) directed against single-stranded DNA containing BrdU (Becton-Dickinson). After three washes, the sections were incubated in a biotinylated horse anti-mouse IgG (Cappel), at 1:50, for 1 hr at room temperature. After three washes, the sections were incubated in avidin-conjugated fluorescein isothiocyanate (FITC; 1:50 dilution; Cappel). Following another three washes, the sections were mounted onto gelled slides and coverslipped with glycerol : water (10: 1). BrdU-immunoreactive cells were examined under a fluorescence microscope with 470 nm wavelength illumination. Immunoreactive cells were counted in the dorsolateral regions of sections extending from the most caudal portion of the genu of the corpus callosum to the level of the crossing of the anterior commissure. The counts were averaged from the dorsolateral regions of two sections per animal, with a minimum of four animals per time point, and expressed as the mean number of BrdU-labeled cells per 350 pm?.
Another group of animals received five injections (one every hour) of BrdU (65 mg/kg) in an attempt to label some subependymal cells heavily for the entire S-phase (4.2 hr), and the animals were then killed 2 or 8 d later. Sections from the same region as described above were examined. By looking for cells that remained labeled after 8 d we could discern whether the proliferating cells remained quiescent after mitosis or whether the population continued to divide.
A separate group of animals received a single injection of BrdU (65 mg/kg, i.p.) and were killed 0.5 hr later, in order to quantify the comparative numbers of cells proliferating in each of the medial edge, the lateral edge, and the dorsolateral comer of the lateral ventricle (Fig. 1) . The number of BrdU-labeled cells in each of the dorsolateral, lateral, and medial areas was counted in two sections from each of four animals.
Retroviral injections. To examine the fate of the mitotically active adult cells, individual proliferating subependymal cells were infected with a retroviral marker that incorporates into DNA and replicates without dilution into all the progeny of the originally infected cell. Lineage analysis by the retroviral method depends on the identification of particular groups of lacZ-positive cells as descendants from a single infected progenitor. For this reason, subependymal cells were exposed to limiting dilutions of the retrovirus (as determined in pilot studies), thus infecting only one or a small number of proliferating cells per mouse. Retrovirus was harvested from the BAG cell line (ATCC CRL-9560) and concentrated using the method of Walsh and Cepko (1988) . Adult CD1 mice were anesthetized using sodium pentobarbital(65 mg/kg, i.p.), and unilateral stereotaxic injections of 0.4 ~1 of recombinant retrovirus were made into the lateral ventricle using a 1 ~1 Hamilton syringe. The coordinates for the injection were AP +4 mm anterior to lambda, L ? 1.9 mm, and DV -2.5 mm below the dura, with the mouth bar at -2 mm below the interaural line. The animals were killed 10 hr (n = 7), 1 d (n = 6), 2 d (n = lo), or 8 d (n = 9) after the retrovirus injection by anesthetic overdose and transcardially perfused with 2% parafotmaldehyde in 0.1 M phosphate buffer. The brains were removed and fixed overnight in 20% sucrose. Serial sections were cut at 56 pm on a cryostat (-14°C) and mounted directly onto gelled slides. The slides were stained for 1acZ at 37°C overnight in the dark in a solution containing 5-bromo-4-chloro-3-indolyl P-n-galactoside (X-gal; Promega) at 1 mg/ml, 20 nM potassium ferrocyanide, 20 mM potassium ferricyanide, and 2 mM MgCl, in phosphate-buffered saline. Before visualizing the 1acZ reaction product, the slides were rinsed in 3% dimethyl sulfoxide in 0.1 M PBS for 5 min, followed by 3 x 1 min rinses in 0.1 M PBS. Slides were coverslipped with glycerol : water (10: 1). In each mouse, the lacZ-positive cells were localized and counted in serial sections from the rostra1 genu of the corpus callosum extending caudally to the start of the third ventricle.
Results
Stress causes an increase in the number of proliferating cells Animals that were injected with 3H-thy and then killed 4 hr later demonstrated labeled cells in the subependymal layer surrounding the lateral ventricles in the forebrain (Fig. 2 ). There were very few cells proliferating in the forebrain outside of the subependyma.
Rarely, proliferating endothelial cells were observed. There was a rostrocaudal gradient with respect to the number of proliferating cells, such that the more rostra1 sections contained more labeled cells (Smart, 1961; Altman, 1963) . In the more caudal sections there was a decrease in the number of labeled cells, and at the rostra1 portion of the third ventricle virtually no labeled subependymal cells were seen. Animals that were stressed by administering anesthetic 24 hr earlier had more than three times as many 3H-thy-labeled subependymal cells than controls (Fig. 3A) , when comparing the mean number of labeled cells surrounding the ventricles (controls, 0.26 f 0.06 cells/350 pm2, n = 4, vs. stress, 0.83 f 0.07/ 350 pm*, n = 5; t, = 6.86; p < 0.05). This increase in the proliferating population was seen using other anesthetics (such as ether) as well as stress by food deprivation (data not shown). Our control group was handled and injected with saline for 7 d in an attempt to minimize the stress associated with an injection. Although we did observe a significant difference in the number of proliferating cells between our control and stressed groups, the control results may not reflect a true resting baseline. There was no significant difference in the average number of Nissl- stained cells per unit area between stressed versus control animals ( Fig. 3B) (control, 15.52 + 3.55 cells/350 prnZ, n = 4, vs. stress, 15.07 * 1.73 cells1350 pm*, y1 = 5; t, = 0.20; p > 0.05). Thus, stress appeared to be increasing the number of 3H-thylabeled cells and not the total number of Nissl-stained cells.
The subependyma was not homogeneous with respect to the number of proliferating cells surrounding the ventricle in sections at any given rostrocaudal level. We divided the subependymal layer into three regions in coronal sections, the dorsolateral corner, the lateral edge, and the medial edge (Fig. 1) . One-half hour after a single BrdU injection, the dorsolateral area demonstrated the most BrdU-labeled cells per unit area, followed by the lateral and medial regions (dorsolateral, 2.18 f 0.69 cells1350 pm*; lateral, 0.71 + 0.13 cells/350 pm2; medial, 0.34 + 0.18 cells/350 pm*; n = 4). The number of proliferating cells differed significantly over these three circumferential regions of the subependyma (F2,6 = 5.63; p < 0.05). The dorsolateral region of the subependymal zone may be a remnant of the lateral migratory stream of the embryonic subventricular zone (Bayer et al., 1990) . To test whether the regional heterogeneity was due to regional differences in total cell density, the total number of Nissl-stained cells per unit area in each of the dorsolateral, lateral, and medial areas was determined. These Nissl counts were taken from sections of the control brains from the first set of experiments. There was no significant difference (F2,6 = 0.155; p > 0.05) among the three regions analyzed in the number of cells per unit area (dorsolateral, 14.12 f 1.40 cells1350 pm*; lateral, 16.08 f 3.78 cells/350 pm*; medial, 16.40 + 5.48 cells/ 350 pm*; n = 4). Hence, the regional variations in mitotic activity were not due to variations in the total number of cells in the subependyma. In general, BrdU labeling produced greater numbers of labeled cells than 3H-thy labeling, presumably due to the visualization of cells through the entire 32 pm sections with BrdU immunoreactivity.
Proliferation kinetics revealed by cumulative BrdU labeling
After a series of BrdU injections into adult mice, the total counts were made of BrdU-labeled and unlabeled cells in the dorsolateral region of the subependyma (Figs. 4,5) . Each injection of BrdU labels only those proliferating cells in the DNA synthetic phase (S-phase) during the time that BrdU is available for incorporation (Packard et al., 1973) . Thus, the fraction of the proliferating population labeled at the instant of the first BrdU injection is equal to the percentage of the total cell cycle time (T,) spent in S-phase (T,), or TJT,. This is equal to the labeling index (LI), the proportion of labeled cells in the total population at any given time (t). In the experiment, the animals were killed 0.5 hr after the initial injection; therefore, the first point on the graph is the labeling index at t = 0.5 (LI,,,). In order to determine TJT, at t = 0, we extrapolated the curve back to t = 0 and determined the LI,.
Since only TJT, of the population are labeled by a single BrdU injection, it is necessary to make a series of injections to label the entire proliferating population. To do this, BrdU was injected every hour. This ensured that the time between the injections was less than T,, so that we would not miss cells as they passed through S-phase between injections. The best-fit curve for the data from O-8.5 hr of BrdU labeling is a straight line (R coefficient = 0.98). The line is the leastsquares fit obtained with the conditions for a one-population model. If there is more than one intermingled cell cycle population in the subependyma, then the slope of the best-fit curve for the data points will not be linear. While the best estimate indicates that a one-population model is appropriate, it remains possible that a small percentage of the proliferating population has different cell cycle kinetics. The number of labeled cells reaches a maximum when all the proliferating cells have been labeled. The time it takes to reach this maximum is equal to 7:. -T, (the time it takes a cell that was just at the end of S-phase when it was first exposed to BrdU to pass through the rest of the cell cycle and then reenter S). Not all the cells in the subependymal zone are proliferating since the maximum number of proliferating cells does not reach 100%. The growth fraction (GF) is the proportion of the total population that is proliferating, and in a single population model, it is derived from the proportion of cells labeled at (or after) T,. -T,. From Figure 4 , we calculate that K. -T, = 8.5 hr, LI, = 1 l%, and GF = 33%. From these data we estimate that T for the population = 12.7 hr and T, = 4.2 hr. The proliferating population comprises 33% of the total subependymal population in the dorsolateral region of the lateral ventricle. This 33% figure may constitute the maximal proliferating population, insofar as the multiple BrdU injections in this experiment were a stress manipulation.
It follows, then, that the remaining 67% of the subependymal cells make up a nondividing population of dorsolateral and subependymal cells.
The intrahilar proliferative zone in the postnatal mouse was previously examined using cumulative BrdU labeling (Nowakowski et al., 1989) . In this region of the brain, the new postmitotic cells normally migrate away from the proliferative zone. To assess the potential cytotoxic effects of BrdU, Nowakowski et al. (1989) looked for pyknotic cells in the intrahilar proliferative zone. Despite the repeated administration of BrdU, no evidence of pyknosis was observed. Furthermore, at the doses used, BrdU has been shown not to affect the ability of neurons to migrate and differentiate in vivo (Miller and Nowakowski, 1988) . These results make it unlikely that our cumulative labeling data reflect any cytotoxic effects of BrdU; however, given that a somewhat different dose schedule was used in the present study, we cannot completely rule out the possibility of some toxicity.
Animals that were injected with BrdU cumulatively over 5 hr, then killed 8 d later, revealed no labeled cells in the subependymal layer. Animals that were given the same BrdU treatment and killed after 2 d had many BrdU-labeled cells in the subependyma. We assume that these cells are proliferating and diluting out the BrdU label at 2 d; however, the difficulty in assessing a change in the intensity of the BrdU labeling did not allow for a more quantitative analysis. The complete lack of 0 I ' I ' I ' I ' I * 1 ' I ' I * I ' I ' I ' 1 ' I ' 0.5 1.5 2.5 3.5 4.5 5.5 6.5 7.5 6.5 9.5 10.5 11.5 12.5 13.5
Time (in hours) after Initial BrdU injection (Figs. 6, 7) . Indeed, over 60% of these one-or two-cell clones were one-cell clones. There was no significant interaction between the number of clones in each of the size categories (1 or 2 cells/clone vs. 3 or 4 cells/ clone vs. >4 cells/clone) and the various survival times examined (F,,,, = 0.19; p > 0.05) . Thus, the number of cells per clone did not vary over the survival times. There was also no significant interaction between the number of clones per brain and the different survival times (F3,28 = 1.57; p > 0.05). Thus, the number of clones per brain did not change significantly over time.
All of the clones were confined to the subependymal layer regardless of the time postinjection. Groups of cells were often observed on opposite sides of the ventricle (i.e., medial vs. lateral) in a given animal. We concluded that these groups were separate clones. Based on the distributions of lacZ-positive cells surrounding the ventricle, we concluded that each cell within a single clone was no greater than 100 pm from its nearest lacZlabeled neighbor in any direction. Increasing the accepted distance between neighboring labeled cells within an individual clone from 100 to 200 pm did not significantly alter the distribution of clone sizes over time (F,56 = 0.7; p > 0.05). Thus, there was no significant difference in the number of cells per clone over the various survival times regardless of whether the accepted distance between the labeled cells for defining a clone was 100 or 200 Frn. This suggests that the original definition of a clone (< 100 pm between labeled cells) was capturing for the most part the progeny of a single infected cell. Most important, individual animals that only contained single clones (n = 4) did not have clones greater than two cells in size, and the cells of these two cell clones were never more than 100 pm apart. Even in two brains with a large number of clones (14 and 19 clones, respectively), the vast majority (> 85%) of the clones were one Retrovirally labeled cells were sometimes observed along the injection tract in the cortex of infected animals. The labeled cells appeared in clusters along the injection tract in some of the cases at all of the survival times examined. These lacZlabeled cells in the cortex were never spatially contiguous with labeled subependymal cells. The size of the clusters did not vary over time, although the morphology of the cells did change with longer survival times. After 10 hr survival the cells along the injection track had no processes, but after 8 d many of the cells had processes. We suggest that the labeled cells in the cortex are the result of simultaneous retroviral uptake by individual cells induced to proliferate by injury, rather than a group of clonally related cells from a single infection. These injury-induced, proliferating cells are most likely astrocytes and/or microglia (Korr et al., 1973; Lindsay, 1986; Graeber et al., 1988; Morshead and van der Kooy, 1990) .
Due to our estimation of T, = 12.7 hr, it should be noted that at 10 hr postlesion it would be impossible to have a clone of three or more cells. From Figure 6 it can be seen that 7% of the clones fall into this category at 10 hr. We hypothesize that this 7% represents the probability of double infection with the retrovirus (i.e., more than one infected cell making up what we have defined as a clone). This, therefore, should provide a good estimate of the rate of double infections at all the survival times examined. By 24 hr, it would likewise be impossible to have a clone of more than four cells with a T, of 12.7 hr. Hence, we hypothesize this clone (1 of 12 observed) represents a double infection.
The retroviral lineage study reveals that the surviving progeny of the proliferating progenitors remain confined to the subependyma and do not migrate into the surrounding tissue. Combined with the finding that 8 d after BrdU was injected (hourly injections for 5 hr) there were no labeled cells in the subependyma, we suggest that the proliferating subependymal cells continue to divide in the subependymal layer (hence diluting the BrdU label) and must undergo some cell death there. Because the vast majority of clones are one or two cells in size, the proliferating population must be dividing in a steady-state mode whereby a stem cell divides and the postmitotic progeny undergo cell death.
Examining the distributions of the numbers of cells per clone at longer survival times, it is apparent that the rate of double infection (approximately 7%) may not account for the somewhat increased frequency of larger clones (3 or 4 cells or >4 cells ner clone) at these longer sur&al times: Perhaps a minority of ;he proliferating population divides and differentiates (dies) with different kinetics. For instance, if the death of some postmitotic progeny occurred longer than 12.7 hr (T,) after the last division, then a few larger clones would result. It is also possible that in a minority of cases, both progeny of a single division die in the subependymal zone. The mean number of clones per brain was larger after 10 hr (mean of 6 clones per brain) than after 1 d (mean of 1.6 clones per brain) survival, although this difference did not reach statistical significance (t,, = 0.09; p > 0.05). The larger mean number of clones per brain at 10 hr was primarily due to two animals with many clones. This variation in the number of clones per brain may hint at the death of both progeny after mitosis in some cases. If this does occur, then the few larger clones that were seen at 8 d may allow for the consistent replacement of subependymal cells that must be necessary to maintain the constant size of the adult subependymal layer.
We can make an estimate of the usual time between proliferation and the death of the postmitotic progeny by noting that at all times of death after retroviral injection, the vast majority of clones are one or two cells in size. This implies that before individual labeled stem cells go through S-phase and mitosis for a second time, the postmitotic progeny must have undergone cell death (i.e., within 12.7 hr). Thus, there was no increase in the number of three-cell clones after 1 and 2 d survival times, despite the fact that the dividing cells continue to be mitotically active.
Discussion
In the postnatal period, the subependymal layer of the rodent forebrain appears as a collection of undifferentiated, mitotically active cells separated from the lumen of the ventricle by a single row of ependymal cells bordering the lateral ventricles. Mitotic activity within the subependymal layer has been consistently reported in postnatal tissue, and it appears to persist throughout adult life (Smart, 196 1; Altman, 1963 Altman, , 1969 Hopewell, 197 1) . We have used continuous BrdU labeling to examine the proliferation kinetics of these subependymal cells in adult mice. The most actively proliferating region surrounding the lateral ventricle is the dorsolateral comer, with a growth fraction of 33%, suggesting that one-third of the cells make up the proliferating portion of the subependymal population in this region. The estimated cell cycle time (T,) for these dividing cells is 12.7 hr, with an S-phase (T,) of approximately 4.2 hr. Previous stud-ies in adult rat tissue have used cumulative 3H-thy experiments to label proliferating subependymal cells and have derived values of T, = 18-2 1 hr and T, = 8.5-12.3 hr, with estimates of the growth fraction varying between 16% and 35% (Lewis, 1968; Lewis et al., 1977; Schultze and Kerr, 198 1) . The differences may be due to the different regions of the subependymal layer examined and to the different species studied. We studied the most mitotically active subependymal region of the adult mouse brain, the dorsolateral region. The growth fraction would have been considerably less had we derived our estimates from the subependyma surrounding the entire ventricle.
The retroviral lineage tracing data reveal that the number of cells per clone (the majority are 1 or 2 cell clones) does not change regardless of the survival time postinfection, and that the labeled cells are always confined to the subependymal zone. Moreover, cumulatively injecting the animals with BrdU over 5 hr, then allowing an 8 d survival time, revealed no labeled cells in the subependyma. This implies that the cells labeled on day 0 do not enter into an extended nonmitotic phase, but continue to divide and dilute the label. Taken together, these data suggest a steady-state mode of subependymal cell proliferation. A single labeled cell divides, and the postmitotic progeny undergoes cell death (hence the clone size remains constant). The remaining progeny goes on to divide again (hence diluting the label), and the one postmitotic cell will once more undergo cell death, repeating the cycle. The observation that the clone size remains the same over time gives an indication of the maximum time that the postmitotic progeny of each division can survive. Since there is no increase in the relative frequency of three-cell clones after 1 or 2 d survival, the postmitotic progeny must be dying before the stem cell goes through mitosis for a second time. From the cumulative labeling study, it follows that the one postmitotic cell from each division must die within 12.7 hr (T,).
It has been generally assumed that new postmitotic subependymal cells migrate out of the subependymal layer to replace degenerating glial cells (Altman, 1966; Lewis, 1968; Privat and Leblond, 1972; Paterson et al., 1973) or to become neurons (Altman, 1969) . This assumption is partially based on the observation that following a single 3H-thy injection there is the exponential decline of the mean grain count per subependymal nucleus as a function of time, indicating continuous division of labeled cells. However, despite this continuous cell division, the number of cells in the subependymal layer does not increase with time (Hopewell, 197 1; present results) . Labeled glial cells and neurons in the regions bordering the ventricles and in the surrounding tissue have been identified after postnatal 'H-thy injections (Altman, 1962 (Altman, , 1963 Privat and Leblond, 1972; Kerr et al., 1973) . These observations were interpreted as indicating that the postmitotic progeny migrate away from the subependymal layer and differentiate into glia or neurons. We tested this hypothesis using retroviral injections into the lateral ventricles to label proliferating subependymal cells, and studying the distributions of labeled cells up to 8 d later. We failed to substantiate the hypothesis. Serial sections of the brain revealed no retrovirally labeled cells in the brain tissue outside of the subependymal layer. Indeed, the only non-subependymal, retrovirally labeled cells were the few, presumably injury-induced, proliferating cells along the retroviral injection track in the cortex. These injection tract cells were not contiguous with the labeled cells in the subependymal layer at any time examined postinfection. We suggest that under normal conditions the subependymal cells do not migrate, or differentiate into glia or neurons. Smart (196 1) also concluded that the proliferating subependymal cells ultimately degenerate within the layer, after finding large numbers of pyknotic subependymal cells in the adult animal. It seems likely that the few 3H-thy-labeled cells outside of the subependyma that led to the initial replacement hypothesis are indicative of normally occurring, but minor, proliferation in adult brain tissue outside of the subependyma (Altman, 1963; Kerr, 1980) . The adult subependymal layer contains actively proliferating cells, yet we can only speculate on the function of these cells. In adult birds, the ventricular zone contains cells that continue to proliferate and migrate out into the regions of the brain important for song production (Alvarez-Buylla et al., 1990; Nordeen and Nordeen, 1990) . The mammalian subependymal zone has been described as a "degenerate remnant" of the embryonic ventricular zone (Smart, 196 1) . While we have no evidence for any functional differentiation of these proliferating subependymal cells, it appears that their mitotic activity can be regulated. It was possible to induce three times the number of 3H-thy-labeled subependymal cells 24 hr after stressing mice. This ability to manipulate the cells suggests that the proliferating subependymal cells may serve some function in the adult brain or, minimally, that they are still responsive to stimuli that influence the cell cycle. We do not know whether stress affects the cells by decreasing T, (and hence we observe more cells after a single BrdU injection) or whether the stress recruits subependymal cells that do not normally comprise the proliferating population. Stress could also prevent some of the stem cells from dying and/or extend the survival time of the postmitotic progeny.
One possible function that could be attributed to the proliferating subependymal cells is that they serve as a reserve source of undifferentiated cells in case of damage to brain tissue. To examine this possibility, a neurotoxin (kainic acid) was injected unilaterally into the adult striatum at the same time that the recombinant retrovirus was injected into the ipsilateral lateral ventricle. The brain tissue was examined 6 d later, at the time of maximum gliosis within the striatum (Morshead and van der Kooy, 1990) to determine if any retrovirally labeled cells appeared in the striatum surrounding the lesion. Preliminary findings revealed that the retrovirally labeled subependymal cells were still confined to the subependymal layer and did not differentiate into glial cells or migrate into the nearby striatal tissue (C. M. Morshead and D. van der Kooy, unpublished observations). It remains possible that the proliferating subependymal cells have the potential to take on a particular striatal phenotype, but have not yet been exposed to the appropriate inducing stimuli. It would be interesting to examine further the potential of these proliferating subependymal cells by exposing them to different environments, for example, by transplanting them to different regions of the adult brain or to an earlier time in development. 
